Status:
UNKNOWN
Predictive Value of HAS-BLED and CHA2DS2-Vasc Scores After PCI
Lead Sponsor:
Assiut University
Conditions:
Percutaneous Coronary Intervention
Eligibility:
All Genders
18+ years
Brief Summary
To assess the predictive value of two scoring systems, namely HAS-BLED and CHA2DS2-VASc scores, to be linked with bleeding events and recurrence of chest pain and other measures of clinical outcome of...
Detailed Description
Dual-antiplatelet therapy (DAPT) with aspirin and an inhibitor of the platelet P2Y12 receptor is necessary to prevent stent-related thrombotic complications after percutaneous coronary intervention (P...
Eligibility Criteria
Inclusion
- all patients undergoing PCI
Exclusion
- Those who had undergone unexpected immediate CABG
Key Trial Info
Start Date :
December 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT04047199
Start Date
December 1 2019
End Date
July 1 2020
Last Update
August 26 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.